Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mNGF for spinocerebellar ataxia
ChiCTR-ONC-11001954Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jul 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rat nerve growth factor in spinocerebellar ataxia (SCA), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: ICARS score, SARA score and 1 more. Started Jul 2011; status: completed.
02
Drugs
rat nerve growth factor
03
Conditions
spinocerebellar ataxia (SCA)
Beyond the preview
Go deeper on ChiCTR-ONC-11001954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-11001954.